NPI: 1942599592 · HIGHLAND, CA 92346 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/05/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/05/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,117 | $1.02M |
| 2019 | 20,587 | $897K |
| 2020 | 17,750 | $983K |
| 2021 | 18,305 | $1.07M |
| 2022 | 21,476 | $1.19M |
| 2023 | 24,369 | $1.22M |
| 2024 | 13,215 | $1.36M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 48,428 | 4,156 | $7.64M |
| A4657 | Syringe, with or without needle, each | 3,005 | 1,862 | $99K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 37,339 | 3,030 | $7K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 831 | 467 | $5K |
| J1756 | Injection, iron sucrose, 1 mg | 11,743 | 2,847 | $2K |
| 90661 | 12 | 12 | $405.35 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 19,681 | 1,780 | $231.36 |
| 82728 | 912 | 789 | $91.28 | |
| 0250 | 6,484 | 455 | $35.00 | |
| 85048 | 1,670 | 1,447 | $0.00 | |
| 83970 | 1,396 | 1,273 | $0.00 | |
| 85041 | 1,708 | 1,481 | $0.00 | |
| 83540 | 1,050 | 885 | $0.00 | |
| 90662 | 19 | 15 | $0.00 | |
| 83550 | 954 | 798 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 436 | 305 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 28 | 27 | $0.00 |
| 90674 | 123 | 117 | $0.00 |